You mean well over 90% right? The only reason A40 is still mcap...

First 18 Last

Share
Profile

Follow
NewLogic

594 Posts.

44

01/09/19

12:33

Post #: 40266276
Share

Originally posted by h0rc0: ↑

Why ? Simple, because without a script offer GXY will not get their hands on A40.

As I see it A40 BOD had something else planned for clearing the debt to Tribbeca and were taken by surprise by GXY buying the debt before the deal could be completed which led to A40 calling the VA which must have took GXY by surprise.
IMO GXY should have came up with an acceptable script offer to do a TO of A40 at the same time they bought the debt from Tribecca and avoid this mess.
Now they can make a deal for A40 script in exchange for the debt which will give them well over 20% ownership and a couple of seats at the table or wait for A40 to finalize a deal with whoever they were trying to deal with before GXY jumped on them and make a few $M profit for their trouble of holding the debt but lose a lot more on the $20M A40 they bought recently at 20c.
As I hold both stocks I would have preferred a script offer to TO the entire A40 so they can get rid of the management and put Bald Hill on C&M until the spod price recovered or alternatively GXY could run Bald Hill directly and have the higher grade from BH blended with Mt Cattlin ore to bring it up to 6%.

Expand

You mean well over 90% right? The only reason A40 is still mcap 120m is because it hasn't traded in over half a month.

GXY Price at posting: $1.16 Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

FHE

Frontier Energy achieves key milestone for Waroona energy project

STX

Strike Energy secures $153 million for Perth Basin gas projects

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

EMD

Emyria's Empax Centre chosen for mental health clinical trial

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

BRX

Belararox delineates another porphyry in Argentina at Tambo South